The SARS-CoV-2 bacterium infection carries a greater risk of thromboembolic complications as well as a better propensity for grieving. We reviewed the relevant PubMed items discussing the prevalence, classification of patients, the moment of incident, and evolution of venous thromboembolism (VTE), but also of venous and arterial “in seated position” thrombosis (AT), and hemorrhagic events also and identified 58 important scientific papers, containing 10 meta- analyses and 19 cohort studies. Depending on the culture under study, most experts agree that there is an increased predominance of thromboembolic events, which can range from 25 to 31% for VTE. Lower occurrence of AT and hemorrhagic complications betwixt 4.8 and 8%, or roughly 2-3%, respectively were written. These events predominantly afflicted elderly patients accompanying moderate- to severe-stage COVID-19 and other comorbidities. It’s lively to note that individuals the one experienced hemorrhages usually secondhand anticoagulant medications for thromboprophylaxis. The evolution of sufferers infected with the SARS-CoV-2 bacterium is exacerbated as a result of thromboembolic and hemorrhagic results, both of which are meaningful negative prognostic indicators, superior to an increased morbidity and death of this population.
Author(s) Details:
Cristina Tudoran,
Department VII, Internal Medicine II, Discipline of Cardiology, University of Medicine and Pharmacy “Victor Babes” Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania, Center of Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, University of Medicine and Pharmacy “Victor Babes” Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania, County Emergency Hospital “Pius Brinzeu”, L. Rebreanu, Nr. 156, 300723 Timisoara, Romania and Academy of Romanian Scientists, Ilfov Str. Nr. 3, 050085 Bucuresti, Romania.
Dana Emilia Velimirovici,
Department VI, Internal Medicine and Ambulatory Care, Prevention and Cardiovascular Recovery, University of Medicine and Pharmacy “Victor Babes” Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.
Delia Mira Berceanu-Vaduva,
Department XIV, Microbiology, University of Medicine and Pharmacy “Victor Babes” Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.
Maria Rada,
Department VI, Internal Medicine and Ambulatory Care, Prevention and Cardiovascular Recovery, University of Medicine and Pharmacy “Victor Babes” Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.
Florica Voita-Mekeres,
Department of Morphological Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 1 Universitatii Street, 410087 Oradea, Romania.
Mariana Tudoran,
County Emergency Hospital “Pius Brinzeu”, L. Rebreanu, Nr. 156, 300723 Timisoara, Romania.
Please see the link here: https://stm.bookpi.org/RAMB-V3/article/view/9765
Keywords: COVID-19, thromboembolic events, arterial thrombotic events, venous thrombotic events,
